학술논문
EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece
Document Type
Abstract
Author
Source
In Value in Health December 2022 25(12) Supplement:S119-S120
Subject
Language
ISSN
1098-3015